Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ODC1 | P11926 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TLR2 | O60603 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21071668 | 0.95 | CYP3A4 (0.46) | CYP3A4ODC1HTTALDH1A1TLR2 | |
| SCHEMBL9291335 | 0.86 | ALDH1A1 (0.36) | CYP3A4ALDH1A1 | |
| SCHEMBL12695269 | 0.85 | ALDH1A1 (0.37) | CYP3A4ALDH1A1 | |
| SCHEMBL12269417 | 0.85 | ALDH1A1 (0.37) | CYP3A4ALDH1A1 | |
| Water SCHEMBL28694307 | 0.83 | ALDH1A1 (0.35) | CYP3A4ALDH1A1 | |
| SCHEMBL9392642 | 0.83 | HTT (0.40) | CYP3A4HTTALDH1A1 | |
| SCHEMBL194541 | 0.83 | ALDH1A1 (0.39) | CYP3A4ALDH1A1 | |
| SCHEMBL28689011 | 0.80 | CYP3A4 (0.33) | CYP3A4TLR2 | |
| SCHEMBL825247 | 0.80 | — | — | |
| SCHEMBL31360426 | 0.80 | CA2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190192398-A1 | Hair Strengthening Ingredient And Hair-Strengthening Method | IP FULL ASSET LIMITED (CN) | 2019-06-27 | — | — | US | claimed |
| EP-2002850-B1 | Adhesive formulations | COVIDIEN LP (US) | 2017-04-05 | — | — | EP | claimed |
| EP-2002850-A2 | Adhesive formulations | Tyco Healthcare Group, LP (US) | 2008-12-17 | — | — | EP | claimed |
| EP-1960446-A2 | BIOCOMPATIBLE SURGICAL COMPOSITIONS | Tyco Healthcare Group, LP (US) | 2008-08-27 | — | — | EP | claimed |
| US-20070135606-A1 | Biocompatible surgical compositions | TYCO HEALTHCARE GROUP LP | 2007-06-14 | — | — | US | claimed |
| WO-2007067764-A2 | BIOCOMPATIBLE SURGICAL COMPOSITIONS | TYCO HEALTHCARE GROUP LP (US) | 2007-06-14 | — | — | WO | claimed |
| EP-2002850-B1 | Adhesive formulations | COVIDIEN LP (US) | 2017-04-05 | — | — | EP | disclosed |
| EP-1962867-B1 | BIOCOMPATIBLE SURGICAL COMPOSITIONS | COVIDIEN LP (US) | 2013-06-19 | — | — | EP | disclosed |
| US-7998466-B2 | Biocompatible tissue sealants and adhesives | TYCO HEALTHCARE GROUP LP (US) | 2011-08-16 | — | — | US | disclosed |
| US-7947263-B2 | Biocompatible surgical compositions | TYCO HEALTHCARE GROUP LP (US) | 2011-05-24 | — | — | US | disclosed |
| EP-2002850-A2 | Adhesive formulations | Tyco Healthcare Group, LP (US) | 2008-12-17 | — | — | EP | disclosed |
| EP-1962867-A2 | BIOCOMPATIBLE SURGICAL COMPOSITIONS | Tyco Healthcare Group, LP (US) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007067621-A2 | BIOCOMPATIBLE SURGICAL COMPOSITIONS | TYCO HEALTHCARE GROUP LP (US) | 2007-06-14 | — | — | WO | disclosed |
| US-20070128153-A1 | Biocompatible surgical compositions | TYCO HEALTHCARE GROUP LP | 2007-06-07 | — | — | US | disclosed |
| US-20070128152-A1 | Biocompatible tissue sealants and adhesives | TYCO HEALTHCARE GROUP LP | 2007-06-07 | — | — | US | disclosed |
| WO-2001040396-A2 | URETHANE MODIFIED EPOXY ADHESIVE COMPOSITION | REICHHOLD, INC. (US) | 2001-06-07 | — | — | WO | disclosed |
| EP-0820492-B1 | EPOXY ADHESIVES WITH DITHIOOXAMIDE ADHESION PROMOTERS | MINNESOTA MINING & MFG (US) | 1999-08-25 | — | — | EP | disclosed |
| US-5712039-A | AMINE CURED EPOXY ADHESIVES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-01-27 | — | — | US | disclosed |
| EP-0726928-A1 | ANTICORROSION ADHESIVE COMPOSITION AND METHOD | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-08-21 | — | — | EP | disclosed |
| WO-1995012647-A1 | ANTICORROSION ADHESIVE COMPOSITION AND METHOD | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070128152-A1 | Biocompatible tissue sealants and adhesives | CDH1, EPCAM, DSP | CYP3A4 4432/4885ODC1 2745/4885HTT 4294/4885 |
| US-20190192398-A1 | Hair Strengthening Ingredient And Hair-Strengthening Method | KRT18, PHB1, PHB2 | CYP3A4 4506/4885ODC1 1125/4885HTT 661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.